TerrAscend (TSNDF) Depreciation & Amortization (CF) (2021 - 2026)

TerrAscend's (TSNDF) quarterly Depreciation & Amortization (CF) came in at $4.1 million in Q1 2026, up 4.92% year-on-year from $3.9 million in Q1 2025, and up 4.6% on a QoQ basis from $4.0 million in Q4 2025.

TerrAscend (TSNDF) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends

TerrAscend (TSNDF) has 6 years of Depreciation & Amortization (CF) data on file, last reported at $4.1 million in Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 4.92% year-over-year to $4.1 million in Q1 2026; TTM through Mar 2026 was $15.8 million, a 17.14% increase from a year earlier, with the FY2025 full-year figure at $15.6 million, up 7.32% from the prior year.
  • Depreciation & Amortization (CF) for Q1 2026 stood at $4.1 million, up from $4.0 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for TSNDF reached as high as $6.6 million in Q2 2022 and fell as low as -$339000.0 in Q4 2023.
  • Historically, Depreciation & Amortization (CF) has averaged $4.2 million across 5 years, with a median of $4.1 million in 2026.
  • Across the five-year window, Depreciation & Amortization (CF) slumped 106.72% in 2023 and soared 1043.36% in 2024, its largest moves.
  • Year by year, Depreciation & Amortization (CF) stood at $5.0 million in 2022, then slumped by 106.72% to -$339000.0 in 2023, then surged by 1043.36% to $3.2 million in 2024, then grew by 23.76% to $4.0 million in 2025, then rose by 4.6% to $4.1 million in 2026.
  • Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $4.1 million in Q1 2026, $4.0 million in Q4 2025, and $3.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 239.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 119.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.04 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 22.60 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 676.10 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 7.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 172.00 Mn
10 TerrAscend 160.44 Mn 162.98 Mn 34.60 Mn 4.14 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.14 Mn
Mar 31, 2026 4.14 Mn
Dec 31, 2025 3.96 Mn
Dec 31, 2025 3.96 Mn
Sep 30, 2025 3.93 Mn
Sep 30, 2025 3.93 Mn
Jun 30, 2025 3.78 Mn
Jun 30, 2025 3.78 Mn
Mar 31, 2025 3.95 Mn
Mar 31, 2025 3.95 Mn
Dec 31, 2024 3.20 Mn
Dec 31, 2024 3.20 Mn
Sep 30, 2024 3.78 Mn
Sep 30, 2024 3.78 Mn
Jun 30, 2024 2.58 Mn
Jun 30, 2024 2.58 Mn
Mar 31, 2024 5.00 Mn
Mar 31, 2024 5.00 Mn
Dec 31, 2023 -339,000.00
Dec 31, 2023 -339,000.00